Aurora Spine Corporation (ASG.V)
CAD 0.43
(1.18%)
CAD 0.43
(1.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.21 Million USD | 6.05% |
| 2022 | 9.15 Million USD | 23.96% |
| 2021 | 7.38 Million USD | 59.41% |
| 2020 | 4.63 Million USD | 0.11% |
| 2019 | 4.62 Million USD | 2.78% |
| 2018 | 4.5 Million USD | -5.03% |
| 2017 | 4.74 Million USD | -5.24% |
| 2016 | 5 Million USD | -13.94% |
| 2015 | 5.81 Million USD | -35.12% |
| 2014 | 8.95 Million USD | 0.0% |
| 2012 | 1.44 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.7 Million USD | 6.85% |
| 2024 Q2 | 2.65 Million USD | -1.76% |
| 2024 Q3 | 2.76 Million USD | 4.1% |
| 2023 Q2 | 2.46 Million USD | 14.71% |
| 2023 Q4 | 2.53 Million USD | -0.92% |
| 2023 Q3 | 2.55 Million USD | 3.65% |
| 2023 FY | 9.7 Million USD | 6.05% |
| 2023 Q1 | 2.15 Million USD | -16.05% |
| 2022 Q2 | 2.32 Million USD | 3.43% |
| 2022 Q1 | 2.24 Million USD | 1.06% |
| 2022 Q4 | 2.56 Million USD | 27.01% |
| 2022 FY | 9.15 Million USD | 23.96% |
| 2022 Q3 | 2.01 Million USD | -13.3% |
| 2021 FY | 7.38 Million USD | 59.41% |
| 2021 Q1 | 1.63 Million USD | 20.0% |
| 2021 Q3 | 1.68 Million USD | -8.4% |
| 2021 Q4 | 2.22 Million USD | 32.0% |
| 2021 Q2 | 1.84 Million USD | 12.73% |
| 2020 Q2 | 826.73 Thousand USD | -36.48% |
| 2020 Q4 | 1.36 Million USD | 18.98% |
| 2020 FY | 4.63 Million USD | 0.11% |
| 2020 Q3 | 1.14 Million USD | 38.31% |
| 2020 Q1 | 1.3 Million USD | 107.7% |
| 2019 Q2 | 1.28 Million USD | -2.71% |
| 2019 FY | 4.62 Million USD | 2.78% |
| 2019 Q4 | 626.59 Thousand USD | -54.82% |
| 2019 Q3 | 1.38 Million USD | 7.6% |
| 2019 Q1 | 1.32 Million USD | 4.61% |
| 2018 Q4 | 1.26 Million USD | 7.45% |
| 2018 FY | 4.5 Million USD | -5.03% |
| 2018 Q1 | 1 Million USD | -16.16% |
| 2018 Q2 | 1.05 Million USD | 5.45% |
| 2018 Q3 | 1.17 Million USD | 11.66% |
| 2017 Q1 | 1.38 Million USD | -5.42% |
| 2017 FY | 4.74 Million USD | -5.24% |
| 2017 Q2 | 1.15 Million USD | -16.76% |
| 2017 Q4 | 1.19 Million USD | 18.77% |
| 2017 Q3 | 1 Million USD | -12.91% |
| 2016 Q1 | 1.11 Million USD | -28.14% |
| 2016 Q3 | 1.29 Million USD | 15.27% |
| 2016 Q4 | 1.46 Million USD | 12.86% |
| 2016 Q2 | 1.12 Million USD | 1.42% |
| 2016 FY | 5 Million USD | -13.94% |
| 2015 Q4 | 1.54 Million USD | 13.85% |
| 2015 Q3 | 1.35 Million USD | 43.37% |
| 2015 FY | 5.81 Million USD | -35.12% |
| 2015 Q2 | 947.41 Thousand USD | -51.68% |
| 2015 Q1 | 1.96 Million USD | -36.85% |
| 2014 Q1 | 1.45 Million USD | 0.0% |
| 2014 Q2 | 1.75 Million USD | 20.79% |
| 2014 Q3 | 2.64 Million USD | 50.23% |
| 2014 Q4 | 3.1 Million USD | 17.55% |
| 2014 FY | 8.95 Million USD | 0.0% |
| 2013 Q3 | 680.88 Thousand USD | 0.0% |
| 2012 FY | 1.44 Million USD | 0.0% |
| 2012 Q3 | 261.61 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | 21.51 Million CAD | 61.83% |
| Therma Bright Inc. | 3.62 Million CAD | -126.391% |
| Theralase Technologies Inc. | 562.13 Thousand CAD | -1360.736% |
| VentriPoint Diagnostics Ltd. | 4.97 Million CAD | -65.12% |